Sketchy- Ultimate Book 2020 (Microbiology, Pharmacology, Pathology)

SketchyMicro

Bacteria
CHAPTER 1 GRAM POSITIVE COCCI
1.1 – Staphylococcus aureus
1.2 – Staphylococcus epidermidis & saprophyticus
1.3 – Streptococcus pyogenes (group A strep)
1.4 – Streptococcus agalactiae (group B strep)
1.5 – Streptococcus pneumoniae & viridans
1.6 – Enterococcus faecium & faecalis
CHAPTER 2 GRAM POSITIVE BACILLI
2.1 – Bacillus anthracis & cereus
2.2 – Clostridium tetani
2.3 – Clostridium botulinum
2.4 – Clostridium difficile
2.5 – Clostridium perfringens
2.6 – Corynebacterium diphtheriae
2.7 – Listeria monocytogenes
CHAPTER 3 GRAM-POSITIVE BRANCHING FILAMENTOUS RODS
3.1 – Actinomyces israelii
3.2 – Nocardia asteroides
CHAPTER 4 GRAM-NEGATIVE COCCI
4.1 – Neisseria overview
4.2 – Neisseria meningitidis
4.3 – Neisseria gonorrhoeae
CHAPTER 5 GRAM-NEGATIVE BACILLI – ENTERIC TRACT
5.1 – Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens
5.2 – Salmonella enteritidis & typhi
5.3 – Shigella spp.
5.4 – Escherichia coli (ETEC, EHEC)
5.5 – Yersinia enterocolitica & pestis
5.6 – Campylobacter jejuni
5.7 – Vibrio spp.
5.8 – Helicobacter pylori
5.9 – Pseudomonas aeruginosa
5.10 – Proteus mirabilis
CHAPTER 6 GRAM-NEGATIVE BACILLI – RESPIRATORY TRACT
6.1 – Bordetella pertussis
6.2 – Haemophilus influenzae
6.3 – Legionella pneumophila
CHAPTER 7 GRAM-NEGATIVE BACILLI – ZOONOTICS
7.1 – Bartonella henselae
7.2 – Brucella spp.
7.3 – Francisella tularensis
7.4 – Pasteurella multocida
CHAPTER 8 MYCOBACTERIA
8.1 – Mycobacterium tuberculosis
8.2 – Mycobacterium leprae
CHAPTER 9 SPIROCHETES
9.1 – Borrelia burgdorferi
9.2 – Leptospira interrogans
9.3 – Treponema pallidum
CHAPTER 10 GRAM-INDETERMINATE BACTERIA
10.1 – Chlamydia trachomatis, Chlamydophila pneumoniae & Chlamydophila psittaci
10.2 – Coxiella burnetii
10.3 – Gardnerella vaginalis
10.4 – Mycoplasma pneumoniae
10.5 – Rickettsia overview
10.6 – Rickettsia prowazekii
10.7 – Rickettsia rickettsii
Fungi
CHAPTER 1 SYSTEMIC MYCOSES
1.1 – Histoplasma capsulatum
1.2 – Blastomyces dermatitidis
1.3 – Coccidioides immitis
1.4 – Paracoccidioides brasiliensis
CHAPTER 2 CUTANEOUS MYCOSES
2.1 – Malassezia furfur
2.2 – Epidermophyton spp., Trichophyton spp., Microsporum spp. (dermatophytes)
2.3 – Sporothrix schenckii
CHAPTER 3 OPPORTUNISTIC FUNGAL INFECTIONS
3.1 – Candida albicans
3.2 – Aspergillus fumigatus
3.3 – Cryptococcus neoformans
3.4 – Mucor spp., Rhizopus spp. (mucormycetes)
3.5 – Pneumocystis jirovecii
Viruses
CHAPTER 1 RNA VIRUSES – POSITIVE SENSE
1.1 – Picornaviridae overview
1.2 – Poliovirus (Picornaviridae)
1.3 – Coxsackievirus A & B (Picornaviridae)
1.4 – Rhinovirus (Picornaviridae)
1.5 – Hepatitis A virus (Picornaviridae)
1.6 – Norovirus/Norwalk virus (Caliciviridae)
1.7 – Flaviviridae overview
1.8 – Hepatitis C virus (Flaviviridae)
1.9 – Eastern/Western/Venezuelan equine encephalitis virus, Rubella virus (Togaviridae)
1.10 – Coronavirus (Coronaviridae)
1.11 – Human immunodeficiency virus (Retroviridae)
CHAPTER 2 RNA VIRUSES – NEGATIVE SENSE
2.1 – Influenzavirus (Orthomyxoviridae)
2.2 – Measles virus, mumps virus, respiratory syncytial virus, parainfluenza virus (Paramyxoviridae)
2.3 – Rabies virus (Rhabdoviridae)
2.4 – Ebolavirus, Marburgvirus (Filoviridae)
2.5 – Hantavirus, California encephalitis virus, Rift Valley fever virus (Bunyaviridae)
2.6 – Lymphocytic choriomeningitis virus (Arenaviridae)
2.7 – Rotavirus, Colorado tick fever virus (Reoviridae)
CHAPTER 3 DNA VIRUSES
3.1 – Herpes simplex virus type 1 & 2 (Herpesviridae)
3.2 – Epstein–Barr virus (Herpesviridae)
3.3 – Cytomegalovirus (Herpesviridae)
3.4 – Varicella-zoster virus (Herpesviridae)
3.5 – HHV-6, roseola (Herpesviridae)
3.6 – HHV-8, Kaposi’s sarcoma (Herpesviridae)
3.7 – JC polyomavirus, BK polyomavirus (Polyomaviridae)
3.8 – Human papillomavirus (Papillomaviridae)
3.9 – Parvovirus B19 (Parvoviridae)
3.10 – Adenovirus (Adenoviridae)
3.11 – Smallpox virus, Cowpox virus, Molluscum contagiosum virus (Poxviridae)
3.12 – Hepatitis B virus (Hepadnaviridae)
Parasites
CHAPTER 1 PROTOZOA OF THE INTESTINAL TRACT
1.1 – Giardia lamblia
1.2 – Entamoeba histolytica
1.3 – Cryptosporidium spp.
CHAPTER 2 PROTOZOA OF THE CNS
2.1 – Toxoplasma gondii
2.2 – Trypanosoma brucei
2.3 – Naegleria fowleri
CHAPTER 3 PROTOZOA OF THE BLOOD
3.1 – Trypanosoma cruzi
3.2 – Babesia spp.
3.3 – Plasmodium malariae, ovale, vivax & falciparum
3.4 – Leishmania braziliensis & donovani
CHAPTER 4 PROTOZOA – OTHER TISSUE
4.1 – Trichomonas vaginalis
CHAPTER 5 HELMINTHS – NEMATODES
5.1 – Enterobius vermicularis, Ancylostoma duodenale, Necator americanus, Ascaris lumbricoides, Strongyloides stercoralis, Trichinella spiralis (intestinal nematodes)
5.2 – Dracunculus medinensis, Wuchereria bancrofti, Onchocerca volvulus, Toxocara canis, Loa loa (tissue nematodes)
CHAPTER 6 HELMINTHS – TREMATODES AND CESTODES
6.1 – Cestodes
6.2 – Trematodes (Schistosomas: causes shistomiasis)

 

Sketchy Pharma

Autonomic Drugs
CHAPTER 1 PARASYMPATHETIC
1.1 – Cholinomimetics
1.2 – Acetylcholinesterase Inhibitors
1.3 – Muscarinic antagonists
CHAPTER 2 SYMPATHETIC
2.1 – Sympathomimetics
2.2 – Indirect sympathomimetics
2.3 – Alpha drugs
2.4 – Beta blockers
Cardiovascular & Renal
CHAPTER 1 HEART FAILURE DRUGS
1.1 – Digoxin, milrinone, nesiritide
1.2 – ACE inhibitors, ARBs, Aliskiren
CHAPTER 2 DIURETICS
2.1 – Acetazolamide, mannitol
2.2 – Loop diuretics
2.3 – Thiazides
2.4 – K+ sparing diuretics
CHAPTER 3 ANTIHYPERTENSIVES
3.1 – Calcium channel blockers
3.2 – Primary hypertension & hypertensive emergency
CHAPTER 4 ANTIARRHYTHMICS
4.1 – Class I A-C
4.2 – Class II
4.3 – Class III
4.4 – Class IV
4.5 – Class V
Blood & Inflammation
CHAPTER 1 ANTICOAGULANTS & THROMBOLYTICS
1.1 – Heparin, LMWH, fondaparinux, direct thrombin inhibitors, Xa inhibitors
1.2 – Warfarin
1.3 – Antiplatelet agents (Aspirin, ADP receptor inhibitors, GP IIb/IIIa, cilostazol, dipyridamole)
1.4 – Thrombolytics (Fibrinolytic’s: TPA’se: Alteplase, reteplase)
CHAPTER 2 DYSLIPIDEMIA DRUGS
2.1 – Statins
2.2 – Cholestyramine, ezetimibe
2.3 – Fibrates, niacin
CHAPTER 3 ANTI-INFLAMMATORY
3.1 – NSAIDs
3.2 – Gout drugs
Smooth Muscle
CHAPTER 1 VASOACTIVE
1.1 – Nitrates
1.2 – Triptans & migraine
1.3 – Prostaglandins, prostacyclin, bosentan, PDE5 inhibitors
CHAPTER 2 ALLERGY & PULMONARY
2.1 – Antihistamines
2.2 – Asthma therapy
GI & Endocrine
CHAPTER 1 GI
1.1 – Antiemetic agents
1.2 – H2 receptor blockers, PPIs
1.3 – Laxatives & antidiarrheal agents
CHAPTER 2 DIABETES
2.1 – Insulin, sulfonylureas, meglitinides, GLP-1 agonists, DPP-4 inhibitors
2.2 – Metformin, thiazolidinediones, pramlintide, SGLT2 inhibitors
CHAPTER 3 THYROID, PARATHYROID & ADRENAL
3.1 – Propylthiouracil, methimazole, levothyroxine
3.2 – Bisphosphonates, raloxifene, denosumab, calcitonin
3.3 – Teriparatide, vitamin D, cinacalcet, sevelamer
3.4 – Glucocorticoids
CHAPTER 4 HYPOTHALAMIC & PITUITARY
4.1 – Growth hormone, mecasermin, octreotide, pegvisomant
4.2 – ADH, DDAVP, ADH receptor antagonists
Neuro/Psych
CHAPTER 1 SEDATIVE-HYPNOTICS
1.1 – Benzodiazepines, flumazenil
1.2 – Nonbenzodiazepine hypnotics, melatonin, ramelteon
1.3 – Barbiturates
CHAPTER 2 ANESTHETICS & ANALGESICS
2.1 – Propofol, etomidate, ketamine
2.2 – Inhaled anesthetics, dantrolene
2.3 – Opiates, naloxone, naltrexone
CHAPTER 3 ANTIDEPRESSANTS & ANXIOLYTICS
3.1 – SSRIs, SNRIs, cyproheptadine
3.2 – Tricyclic antidepressants
3.3 – MAO inhibitors
3.4 – Bupropion, mirtazapine, trazodone
CHAPTER 4 MOOD STABILIZERS & ANTIEPILEPTIC DRUGS
4.1 – Lithium
4.2 – Valproate, topiramate, lamotrigine, levetiracetam
4.3 – Carbamazepine, phenytoin, gabapentin, tiagabine, vigabatrin
4.4 – Ethosuximide
CHAPTER 5 ANTIPSYCHOTICS & PARKINSON’S
5.1 – First generation antipsychotics
5.2 – Second generation antipsychotics
5.3 – Levodopa/carbidopa, entacapone, tolcapone, selegiline, ropinirole, pramipexole, amantadine
Antimicrobials
CHAPTER 1 CELL WALL AND MEMBRANE ACTIVE ANTIBIOTICS
1.1 – Penicillin
1.2 – Nafcillin, Oxacillin, Methicillin & Dicloxacillin
1.3 – Ampicillin, Amoxicillin, Piperacillin, Ticarcillin (Extended Spectrum Penicillin’s: Beta Lactamase inhibitors)
1.4 – Cephalosporins
1.5 – Monobactams & Carbapenems
1.6 – Vancomycin
1.7 – Daptomycin
CHAPTER 2 INHIBITORS OF BACTERIAL PROTEIN SYNTHESIS
2.1 – Tetracyclines
2.2 – Macrolides
2.3 – Clindamycin
2.4 – Chloramphenicol
2.5 – Linezolid
2.6 – Aminoglycosides
CHAPTER 3 ANTIMYCOBACTERIALS
3.1 – Tuberculosis Drugs (RIPE: The Magnificent 4 – used against mycobacterium infections)
3.2 – Leprosy drugs
CHAPTER 4 OTHER ANTIBIOTICS
4.1 – Trimethoprim/Sulfamethoxazole
4.2 – Fluoroquinolones
4.3 – Metronidazole
CHAPTER 5 ANTIFUNGALS
5.1 – Amphotericin, flucytosine
5.2 – Azoles
5.3 – Griseofulvin, Terbinafine, Echinocandins
CHAPTER 6 ANTIVIRALS: HIV
6.1 – NRTIs
6.2 – NNRTIs
6.3 – Protease inhibitors
6.4 – Maraviroc, fusion inhibitors, integrase inhibitors
CHAPTER 7 ANTIVIRALS: HEPATITIS
7.1 – Interferon α, β, γ
7.2 – Ribavirin, sofosbuvir, simeprevir
CHAPTER 8 ANTIVIRALS: OTHER
8.1 – Acyclovir, valacyclovir, famciclovir
8.2 – Ganciclovir, valganciclovir, foscarnet, cidofovir
Antineoplastics
CHAPTER 1 ANTIMETABOLITES
1.1 – Methotrexate, leucovorin, 5-fluorouracil, hydroxyurea
1.2 – Azathioprine, 6-mercaptopurine, mycophenolate mofetil
1.3 – Cladribine, cytarabine, gemcitabine
CHAPTER 2 DNA & CELLULAR DIVISION
2.1 – Cyclophosphamide, ifosfamide, busulifan, nitrosoureas (carmustine, lomustine, streptozocin)
2.2 – Cisplatin, carboplatin, oxaliplatin, amifostine
2.3 – Bleomycin, doxorubicin, daunorubicin, actinomycin D
2.4 – Etoposide, teniposide, topotecan, irinotecan
2.5 – Vincristine, vinblastine, paclitaxel
CHAPTER 3 KINASE INHIBITORS & MONOCLONAL ANTIBODIES
3.1 – Imatinib, erlotinib, sorafenib, sunitinib, vemurafenib
3.2 – Rituximab, cetuximab, bevacizumab, alemtuzumab, trastuzumab

 

Sketchy Patho

Cardiac
CHAPTER 1 ISCHEMIC HEART DISEASE
1.1 – Myocardial Response To Ischemia
1.2 – Stable Angina, Vasospastic Angina, & Acute Coronary Syndromes (UA, NSTEMI, STEMI)
1.3 – Acute Myocardial Infarction & Post-MI Timeline
CHAPTER 2 HEART FAILURE
2.1 – Congestive Heart Failure – Pathophysiology
2.2 – Congestive Heart Failure – Clinical Manifestations
CHAPTER 3 MYOCARDIAL & PERICARDIAL DISORDERS
3.1 – Dilated and Restrictive Cardiomyopathy
3.2 – Hypertrophic Cardiomyopathy
3.3 – Myocarditis
3.4 – Pericarditis & Constrictive Pericarditis
CHAPTER 4 VALVULAR DISORDERS
4.1 – Mitral Stenosis, Acute Rheumatic Fever & Rheumatic Heart Disease
4.2 – Mitral Valve Regurgitation and Prolapse
4.3 – Aortic Stenosis and Regurgitation
CHAPTER 5 CONGENITAL HEART DISEASE
5.1 – Left-to-Right Shunts
5.2 – Right-to-Left Shunts
Vascular
CHAPTER 1 ATHEROSCLEROSIS
1.1 – Atherosclerosis: Pathophysiology
1.2 – Peripheral Artery Disease
CHAPTER 2 HYPERTENSION
2.1 – Hypertension
2.2 – Aortic Aneurysm
2.3 – Aortic Dissection
CHAPTER 3 VASCULITIDES
3.1 – Large & Medium Vessel Vasculitides
3.2 – Small Vessel Vasculitides
Pulmonary
CHAPTER 1 OBSTRUCTIVE LUNG DISEASE
1.1 – COPD & Emphysema
1.2 – Asthma & Bronchiectasis
CHAPTER 2 RESTRICTIVE LUNG DISEASE
2.1 – Restrictive Lung Disease (Overview)
2.2 – Idiopathic Pulmonary Fibrosis
2.3 – Pneumoconioses
2.4 – Sarcoidosis & Berylliosis
CHAPTER 3 ACUTE LUNG DISORDERS
3.1 – Pneumothorax
3.2 – Acute Respiratory Distress Syndrome (ARDS)
3.3 – Deep Vein Thrombosis & Pulmonary Embolism
CHAPTER 4 LUNG CANCER
4.1 – Lung Carcinoma
Renal
CHAPTER 1 ACUTE KIDNEY INJURY
1.1 – Renal Function Tests & Acute Kidney Injury (AKI)
1.2 – Acute Tubular Necrosis (ATN)
1.3 – Tubulointerstitial Nephritis
CHAPTER 2 GLOMERULOPATHY
2.1 – Nephrotic Syndrome
2.2 – Nephritic Syndrome
CHAPTER 3 CONGENITAL & CHRONIC KIDNEY DISEASE
3.1 – Congenital & Cystic Kidney Disease
3.2 – Chronic Kidney Disease (CKD)
CHAPTER 4 URINARY TRACT OBSTRUCTION
4.1 – Hydronephrosis & Urinary Tract Obstruction
4.2 – Calcium Oxalate Stones & Calcium Phosphate Stones
4.3 – Magnesium Ammonium Phosphate (MAP) Stones, Uric Acid Stones, & Cystine Stones
CHAPTER 5 RENAL CANCER
5.1 – Renal Cell Carcinoma & Nephroblastoma
CHAPTER 6 VOLUME, ELECTROLYTE & ACID/BASE DISORDERS
6.1 – Osmolality & Sodium Disorders
6.2 – Potassium Disorders
6.3 – Calcium Disorders
6.4 – Acid/Base Disorders
6.5 – Renal Tubular Acidosis (RTA)
GI
CHAPTER 1 ESOPHAGEAL & GASTRIC DISORDERS
1.1 – Structural Esophageal Disorders & GERD
1.2 – Esophageal Dysmotility & Cancer
1.3 – Acute and Chronic Gastritis & Peptic Ulcer Disease
1.4 – Gastric Dysmotility & Cancer
CHAPTER 2 SMALL BOWEL DISORDERS
2.1 – Small Bowel Obstruction, Ileus & Hernias
2.2 – Carcinoid Tumor & Small Bowel Neoplasms
2.3 – Intestinal Ischemia & Angiodysplasia
2.4 – Congenital GI Disorders
CHAPTER 3 COLORECTAL & ANAL DISORDERS
3.1 – Large Bowel & Appendiceal Disorders
3.2 – Crohn’s Disease & Ulcerative Colitis
3.3 – Colorectal Polyps & Cancer
3.4 – Anorectal Disorders
Hepatobiliary
CHAPTER 1 GALLBLADDER & BILIARY TRACT DISEASE
1.1 – Lab Evaluation of Liver Injury & Hyperbilirubinemia
1.2 – Gallbladder & Biliary Tract Disease
1.3 – Autoimmune Biliary Tract Disorders & Cancer
CHAPTER 2 LIVER DISEASE
2.1 – Cirrhosis – Pathogenesis & Clinical Manifestations
2.2 – Hereditary Hemochromatosis & Wilson’s Disease
2.3 – Alcoholic and Non-alcoholic Fatty Liver Disease
2.4 – Liver Tumors & Hepatocellular Carcinoma
CHAPTER 3 PANCREATIC DISEASE
3.1 – Acute & Chronic Pancreatitis
3.2 – Pancreatic Cancer & Islet Cell Tumors
Endocrine
CHAPTER 1 HYPOTHALAMIC & PITUITARY DISORDERS
1.1 – Hypothalamic & Pituitary Dysfunction – Etiologies
1.2 – Hypothalamic & Pituitary Dysfunction – Clinical Manifestations
1.3 – Hyperpituitarism
1.4 – Diabetes Insipidus & SIADH
CHAPTER 2 ADRENAL DISORDERS
2.1 – Adrenal Insufficiency
2.2 – Congenital Adrenal Hyperplasia (CAH)
2.3 – Adrenocortical Hyperfunction: Hyperaldosteronism & Hypercortisolism
2.4 – Cushing’s Syndrome
2.5 – Pheochromocytoma & Neuroblastoma
CHAPTER 3 DIABETES
3.1 – Diabetes Mellitus: Pathogenesis & Acute Clinical Manifestations
3.2 – Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS)
3.3 – Diabetes Mellitus: Chronic Complications
CHAPTER 4 THYROID & PARATHYROID
4.1 – Hypothyroidism: Overview & Hashimoto’s Thyroiditis
4.2 – Hypothyroidism: Other Causes
4.3 – Hyperthyroidism: Overview & Graves’ Disease
4.4 – Thyroid Nodules & Cancer
4.5 – Parathyroid Gland Disorders
4.6 – Multiple Endocrine Neoplasia (MEN)
Reproductive & GU
CHAPTER 1 UTERINE & VULVOVAGINAL DISORDERS
1.1 – Abnormal Uterine Bleeding (AUB) & Endometriosis
1.2 – Cervical Neoplasia
1.3 – Vulvar & Vaginal Lesions
CHAPTER 2 REPRODUCTIVE HORMONES & OVARIAN DISORDERS
2.1 – Reproductive Hormones Overview & Polycystic Ovary Syndrome (PCOS)
2.2 – Amenorrhea
2.3 – Ovarian Cysts & Epithelial Ovarian Cancer
2.4 – Ovarian Neoplasms (Germ Cell & Sex Chord-Stromal Tumors)
CHAPTER 3 GESTATIONAL DISORDERS
3.1 – Hydatidiform Mole & Choriocarcinoma
3.2 – Gestational Disorders
3.3 – Polyhydramnios & Oligohydramnios
CHAPTER 4 BREAST
4.1 – Benign Breast Disorders
4.2 – Breast Cancer
CHAPTER 5 MALE GU
5.1 – Testicular Disorders & Cancer
5.2 – Benign Prostatic Hyperplasia (BPH) & Prostate Cancer
5.3 – Bladder Cancer & Penile Disorders
Blood & Coagulation
CHAPTER 1 MICROCYTIC ANEMIAS
1.1 – Microcytic Anemia: Overview & Thalassemias
1.2 – Iron Deficiency Anemia & Anemia of Chronic Disease
CHAPTER 2 NORMOCYTIC & MACROCYTIC ANEMIAS
2.1 – Extravascular Hemolysis: Overview & RBC Membrane Defects
2.2 – Intravascular Hemolysis: Overiew & Paroxysmal Nocturnal Hemoglobinuria (PNH)
2.3 – G6PD Deficiency & Autoimmune Hemolytic Anemia (AIHA)
2.4 – Sickle Cell Disease
2.5 – Megaloblastic Anemia: Folate Deficiency & Vitamin B12 Deficiency
CHAPTER 3 COAGULOPATHIES & PLATELET DISORDERS
3.1 – Quantitative Platelet Disorders
3.2 – Qualitative Platelet Disorders
3.3 – Inherited Coagulation Defects
3.4 – Acquired Coagulation Defects
3.5 – Acquired & Inherited Thrombosis Syndromes
Myeloid & Lymphoid
CHAPTER 1 MYELOID DISORDERS
1.1 – Myeloproliferative Neoplasms & Myelodysplastic Syndromes
1.2 – Acute Myeloid Leukemia (AML) & Chronic Myeloid Leukemia (CML)
1.3 – Polycythemia
CHAPTER 2 LYMPHOID & PLASMA CELL DISORDERS
2.1 – Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Hairy Cell Leukemia & Adult T-cell Leukemia
2.2 – Hodgkin Lymphoma
2.3 – Non-Hodgkin Lymphoma
2.4 – Plasma Cell Neoplasms
Immunology
CHAPTER 1 AUTOIMMUNE & AMYLOIDOSIS
1.1 – Autoimmune Disease: Overview & Systemic Lupus Erythematosus (SLE)
1.2 – Sjogren’s Syndrome, Systemic Sclerosis & Mixed Connective Tissue Disease
1.3 – Polymyositis & Dermatomyositis
1.4 – Amyloidosis
CHAPTER 2 IMMUNODEFICIENCY
2.1 – B-Cell Disorders & DiGeorge Syndrome
2.2 – Combined B & T-Cell Disorders
2.3 – Complement System Disorders
2.4 – Phagocytic Cell Disorders
Musculoskeletal & Derm
CHAPTER 1 BONE
1.1 – Osteoporosis & Paget Disease of Bone
1.2 – Osteomalacia & Rickets
1.3 – Benign Bone Tumors
1.4 – Malignant Bone Tumors
1.5 – Congenital Bone Disorders: Osteogenesis Imperfecta, Achondroplasia & Osteopetrosis
CHAPTER 2 JOINT
2.1 – Osteoarthritis
2.2 – Rheumatoid Arthritis
2.3 – Gout & Pseudogout
CHAPTER 3 MUSCLE
3.1 – Muscular Dystrophies
3.2 – Myasthenia Gravis & Lambert-Eaton Myasthenic Syndrome
CHAPTER 4 DERM
4.1 – Actinic Keratosis, Squamous Cell Carcinoma & Basal Cell Carcinoma
4.2 – Malignant Melanoma
Neuro
CHAPTER 1 CEREBROVASCULAR
1.1 – Epidural Hematoma, Subdural Hematoma, & Subarachnoid Hemorrhage
1.2 – Ischemic & Hemorrhagic Stroke
CHAPTER 2 INTRACRANIAL HYPERTENSION AND TUMORS
2.1 – Intracranial Hypertension (ICH)
2.2 – Hydrocephalus
2.3 – Adult CNS Tumors
2.4 – Pediatric CNS Tumors
CHAPTER 3 SPINAL CORD & PERIPHERAL NERVE
3.1 – Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis (ALS) & Friedreich Ataxia
3.2 – Multiple Sclerosis
3.3 – Guillain-Barré & Charcot-Marie-Tooth
CHAPTER 4 CONGENITAL & NEUROCUTANEOUS
4.1 – Neural Tube Defects, Holoprosencephaly, Chiari Malformation & Syringomyelia
4.2 – Sturge-Weber & Tuberous Sclerosis
4.3 – Neurofibromatosis
CHAPTER 5 NEURODEGENERATIVE
5.1 – Alzheimer Disease & Dementia
5.2 – Creutzfeldt-Jakob Disease, Parkinson’s Disease & Huntington’s Disease